Eric Bachman MD PhD
Diabetes, Lipid Metabolism, Obesity
Translational Medicine
Join to View Full Profile
50 Northern AveBoston, MA 02210
Phone+1 857-207-0405
Dr. Bachman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2001- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1995 - 1998
Duke University School of MedicineClass of 1995
Certifications & Licensure
MA State Medical License 1998 - 2015
Publications & Presentations
PubMed
- 10 citationsPhase 1 Study to Assess the Safety and Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Subjects Without Cystic Fibrosis With Moderate Hepatic Impairment.Lakshmi Viswanathan, Eric Bachman, Simon Tian, Neil Ahluwalia, Yaohua Zhang
European Journal of Drug Metabolism and Pharmacokinetics. 2022-11-01 - 51 citationsThe effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes.Yan-Ling He, William Haynes, Charles D. Meyers, Ahmed Amer, Yiming Zhang
Diabetes, Obesity & Metabolism. 2019-06-01 - 234 citationsRavulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study.Austin G. Kulasekararaj, Anita J. Hill, Scott T. Rottinghaus, Saskia Langemeijer, Richard A. Wells
Blood. 2019-02-07
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
